The Israeli-based company, Allium Medical Solutions, specializes in the development and international distribution of minimally invasive medical products. Their product portfolio includes 'ProCatid', an embolic protection system for Carotid arteries, and 'TruLeaf', which addresses mitral valve regurgitation. Allium Medical Solutions caters to physicians worldwide, offering a wide range of products to treat various diseases. Founded in 2001, the company is focused on improving patient recovery processes and shortening them through their innovative medical devices. Additionally, Allium Medical Solutions conducts research and development in peripheral stents and medical devices, with a particular focus on site-specific stents and minimal invasive therapy for type 2 diabetes treatment.